Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm

Oral Dis. 2015 Jan;21(1):57-65. doi: 10.1111/odi.12207. Epub 2013 Dec 10.

Abstract

Objective: The antimicrobial action of five drugs incorporated in temporary denture relines on the fungal biofilm was evaluated.

Materials and methods: A Candida albicans biofilm (SC5314) was formed on specimens (10 × 1 mm) of materials (Trusoft and Softone) modified or not (control) by the drugs (nystatin, miconazole, ketoconazole, itraconazole, and chlorhexidine diacetate). Cell viability was determined spectrophotometrically by the tetrazolium salt reduction assay (XTT) after 24 h, 48 h, and 7 and 14 days of incubation. The minimum inhibitory concentrations (MICs) were those which inhibited 90% or more of fungal growth. Fungal susceptibility was confirmed by confocal laser scanning microscopy analysis.

Results: The MICs of drugs incorporated in the materials were 0.032, 0.256, 0.128, 0.256, and 0.064 g ml(-1) for nystatin, miconazole, ketoconazole, itraconazole, and chlorhexidine, respectively. Images from nystatin, chlorhexidine, and ketoconazole demonstrated no viable cells.

Conclusions: The antimicrobials incorporated in the resilient materials inhibited fungal growth during 14 days, with lower MICs for nystatin and chlorhexidine.

Keywords: Candida albicans; anti-infective agents; denture liners; denture stomatitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / pharmacology*
  • Biofilms / drug effects*
  • Biofilms / growth & development
  • Candida albicans / drug effects*
  • Candida albicans / growth & development
  • Chlorhexidine
  • Denture Liners / microbiology*
  • Itraconazole / pharmacology
  • Ketoconazole / pharmacology
  • Miconazole / pharmacology
  • Microbial Sensitivity Tests
  • Nystatin / pharmacology

Substances

  • Antifungal Agents
  • Nystatin
  • Itraconazole
  • Miconazole
  • Chlorhexidine
  • Ketoconazole